Medicinal products for gene therapies
Original notice title
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
55 / 100
Risk factors
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 65.8M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 2 lots
- Duration until Apr 2031
- Supply of advanced gene therapy medicinal products for spinal muscular atrophy and hemophilia B.
- Destined for patients of the Canary Health Service (Servicio Canario de la Salud).
Show full summary
This tender is for a Dynamic Purchasing System (DPS) for the supply of advanced gene therapy medicines for spinal muscular atrophy (SMA) and hemophilia B to patients of the Canary Health Service. The DPS is divided into two lots with a total estimated value of €65,765,376. The procedure is restricted, award is based solely on price (100% weight), and submissions are electronic in Spanish. Tenderers may only bid for one lot.
Risks
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Restricted procedure: only invited candidates may submit tenders.
- Electronic submission is required.
- All documents must be in Spanish.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Buyer
Location
Las Palmas de Gran Canaria, ESP
Buyer profile
Identifier
21058580149618
Activity
Health
Lots (2)
LOT-0001
Terapia génica para la atrofia muscular espinal
Supply of gene therapy for spinal muscular atrophy (SMA).
EUR 65.8M
Estimated value
Location
Duration
Category
Award Criteria
Award details
precio. . Precio.
Value note
Show original TED data
Original TED description
Terapia génica para la atrofia muscular espinal
LOT-0002
Terapia génica para la hemofilia B
Supply of gene therapy for hemophilia B.
EUR 65.8M
Estimated value
Location
Duration
Category
Award Criteria
Award details
precio. . Price.
Value note
Show original TED data
Original TED description
Terapia génica para la hemofilia B
Procurement Details
- Publication date
- 19 Apr 2026
- Languages
- Spanish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 267052-2026
Documents (1)
Similar tenders
Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM
France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026
Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek
Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK
France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
55 / 100
Risk factors
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications